Pedro Armando Manjarrez Dominguez, | |
101 Peter Thein Ave Unit D, Belgium, WI 53004-9520 | |
(479) 249-5624 | |
Not Available |
Full Name | Pedro Armando Manjarrez Dominguez |
---|---|
Gender | Male |
Speciality | Speech-language Pathologist |
Location | 101 Peter Thein Ave Unit D, Belgium, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255861928 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 4424-154 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Pedro Armando Manjarrez Dominguez, 101 Peter Thein Ave Unit D, Belgium, WI 53004-9520 Ph: (479) 249-5624 | Pedro Armando Manjarrez Dominguez, 101 Peter Thein Ave Unit D, Belgium, WI 53004-9520 Ph: (479) 249-5624 |
News Archive
Vitamin D may be an effective therapy to treat and even prevent allergy to a common mold that can cause severe complications for patients with cystic fibrosis and asthma.
Merck said today that Travis County, Texas District Court Judge Scott H. Jenkins granted Merck's motion for summary judgment, dismissing all claims in a VIOXX-related lawsuit filed on behalf of the State of Texas.
Research findings demonstrating how genetic expression can be modified with natural substances to prevent chronic illness was the topic of an address by Jeffrey Bland, Ph.D., FACN, FACB, at the 8th Annual Scripps Center for Integrative Medicine 2011 conference in San Diego, California, January 13 - 16.
ChemoCentryx, Inc., today announced that it reported positive preclinical and Phase I study results at the European Association for the Study of Diabetes (EASD). CCX140, a novel, orally bioavailable small molecule antagonist of the chemokine receptor CCR2, improved metabolic function while significantly reducing inflammatory macrophages found in adipose tissue in an animal model, and was well tolerated in Phase I clinical trials.
› Verified 7 days ago